Table 2 Characteristics of the NAFLD Patients With and Without diabetes mellitus
Variable | diabetic NAFLD (n = 114) | non-diabetic NAFLD (n = 726) | P value |
|---|---|---|---|
Age (yr) | 45.3 ± 12.7 | 46.2 ± 12.3 | 0.301 |
Body mass index (kg/m2) | 26.9 ± 2.3 | 26.2 ± 2.8 | 0.232 |
Systolic blood pressure (mmHg) | 133.1 ± 17.1 | 131.6 ± 15.8 | 0.417 |
Diastolic blood pressure (mmHg) | 81.1 ± 11.1 | 81.8 ± 37.2 | 0.709 |
Alanine aminotransferase (U/L) | 32(9–138) | 28 (6–184) | 0.101 |
Aspertate aminotransferase (U/L) | 27 (15–122) | 24 (12–103) | 0.095 |
Glutamyltransferase (U/L) | 41(12–190) | 33 (7–340) | 0.041 |
Creatine Kinase (U/L) | 92(39–330) | 91(17–287) | 0.215 |
Triglyceride (mmol/L) | 1.98 (0.80–9.07) | 1.61(0.34–20.30) | 0.004 |
Total cholesterol (mmol/L) | 5.12 ± 1.04 | 5.05 ± 0.97 | 0.295 |
High-density lipoprotein cholesterol (mmol/L) | 0.98 ± 0.23 | 1.05 ± 0.27 | 0.091 |
Low-density lipoprotein cholesterol (mmol/L) | 3.09 ± 0.80 | 2.97 ± 0.59 | 0.358 |
Fasting plasma glucose (mmol/L) | 6.97(5.39–16.01) | 5.02(3.39–6.01) | <0.001 |
Uric acid (umol/L) | 384.7 ± 67.0 | 361.1 ± 81.4 | 0.014 |
Hemoglobin A1c (%) | 7.2 (5.6–12.5) | 5.5 (4.6–5.8) | <0.001 |
Homocysteine (umol/L) | 16.3(5.3–150.3) | 17.2(4.2–126.2) | 0.241 |
Fe (umol/L) | 24.1(9.4–52.4) | 23.2(8.1–106.1) | 0.346 |
Sialic acid (mg/dL) | 78.6 ± 8.1 | 66.1 ± 6.7 | <0.001 |
High-sensitivity C-reactive protein (mg/L) | 2.0 (0.6–15.2) | 1.9 (0.3–10.2) | 0.079 |
White blood cell (109/L) | 6.9 (4.3–12.3) | 6.5(3.9–14.6) | 0.048 |
Pancreatic Lipase (U/L) | 29 (4–186) | 28(6–319) | 0.194 |
Amylase (U/L) | 36 (23–86) | 45(21–207) | <0.001 |
Free fatty acid (mmol/L) | 0.76(0.3–2.8) | 0.62(0.12–3.40) | 0.007 |
Hemoglobin (g/L) | 156.6 ± 13.4 | 154.3 ± 13.3 | 0.602 |
Platelet (109/L) | 230.3 ± 56.5 | 233.2 ± 52.3 | 0.484 |
Red blood cell distribution width | 13.7(11.6–18.2) | 13.0(11.6–19.7) | 0.785 |
